This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will the Reopening Save Us from Deflation?
by Mark Vickery
We see some disparity between attempts to solve the economy during this pandemic crisis and how much small business believes that relief will be forthcoming.
Solar ETF Shines on Mostly Upbeat Q1 Earnings
by Sanghamitra Saha
Solar companies' earnings came in upbeat-to-mixed in Q1, which facilitated a super rally in the pure-play fund past week.
Tech Rally Helps Nasdaq Turn Positive for 2020: ETFs to Play
by Sweta Jaiswal, FRM
Here we present ETFs that can gain from Nasdaq's return to positive territory.
-20.5M April Jobs Lowest in History; Markets Rally
by Mark Vickery
The Unemployment Rate shot up to 14.7%, a post-World War II high. Indexes are 1% higher in pre-market trading.
Zacks Market Edge Highlights: VOO, RSP, QQQ, DIA and SPY
by Zacks Equity Research
Zacks Market Edge Highlights: VOO, RSP, QQQ, DIA and SPY
Is Warren Buffett Right About Buying the Indexes?
by Tracey Ryniec
In Berkshire Hathaway's annual meeting on May 2, Buffett cautioned against thinking you can beat the market through stock picking.
Mid-Cap Value & Leveraged Natural Gas: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
VOE and BOIL ETFs traded with massive volumes on May 5.
Jobs Numbers Coming This Week; Tyson (TSN) Underperforms
by Mark Vickery
None of this week's jobs numbers are expected to bring good news, but absorbing the impact of current conditions is part of the healing process.
Senior Loan and Inverse Leveraged Small-Cap: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
SRLN and SRTY ETFs traded with massive volumes on May 1.
ETF Asset Report of Coronavirus-Inflicted April
by Sanghamitra Saha
These ETF areas have gained or lost assets in the month of April.
"This Time Is Different!" No, Seriously!
by John Blank
Zacks economists don't want to push the envelope. We wish to provide modest guidance, for how investors can better interpret this current market environment.
Leveraged Small-Cap and Inverse Leveraged Gold Miners: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
URTY and JDST have seen elevated trading volume on Wednesday.
Starting Slow for a Busy Week
by Mark Vickery
We are currently in the heart of earnings season, though the marquee names don't begin reporting until tomorrow.
Inverse Leveraged Brazil and Gold Miners: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
BZQ and DUST have seen elevated trading volume on Friday.
FAANG ETFs in the Spotlight Ahead of Q1 Earnings
by Sweta Killa
The social distancing and stay-at-home mandates led to increased demand for two of the FAANGs - Netflix and Amazon.
Markets Up on COVID-19 Treatment Data
by Mark Vickery
Remsdesivir, a daily infusion treatment from Gilead Sciences (GILD) that has so far shown positive results in a phase-3 study at the University of Chicago Medicine.
Energy and Small-Cap: 2 ETFs to Watch for Outsized Volume
by Sweta Killa
IEZ and IWC saw outsized volume in yesterday trading session.
Energy and Large Caps: 2 ETFs to Watch for Outsized Volume
by Sweta Killa
FXN and IVE saw outsized volume in Thursday trading session.
Jobless Claims Dismal, but the Fed Is the Cavalry
by Mark Vickery
The Federal Reserve is injecting another $2.3 trillion in programs to support the U.S. economy.
Dividend and TIPS: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
DGRO and TIP saw outsized volume in yesterday trading session.
Markets at Halfway Point of Highs & Lows
by Mark Vickery
We now see the S&P 500 roughly halfway between its all-time highs on February 19 of this year and its multi-year lows on March 23.
Quality and Healthcare: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
QUAL and IHI saw outsized volume in yesterday trading session.
4 Sector ETFs That Were Up About Double Digit on Monday
by Sanghamitra Saha
These sector ETFs gained close to double digits on Monday???s trading session.
Markets Bullish on Coronavirus Progress
by Mark Vickery
"Flattening the curve" measures are beginning to bear fruit, as are announcements from myriad pharmaceutical companies vying to develop near-term therapeutics and longer-term vaccines for the coronavirus.
The Stock Market Is Now Tied To Pandemic Data
by Daniel Laboe
Last week we saw the worst weekly unemployment claim in history and the market barely wavered - today we see a 1-day decline in new US cases and the S&P 500 rallies over 7%